MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-22-2023
NantHealth Cash and Cash Equivalents 2011-2026 | NH
Annual Cash and Cash Equivalents NantHealth
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.76 M | 29.1 M | 22.8 M | 5.24 M | 18.3 M | 61.7 M | 160 M | 5.99 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 160 M | 1.76 M | 38.1 M |
Quarterly Cash and Cash Equivalents NantHealth
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.82 M | 14.1 M | 1.76 M | 2.44 M | - | 18.3 M | 29.1 M | 47.8 M | 52 M | 10.8 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 61.7 M | 61.7 M | 61.7 M | 61.7 M | 158 M | 158 M | 160 M | 160 M | 5.99 M | 5.99 M | 5.99 M | - | 3.7 M | - | - | - | 17 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 160 M | 1.76 M | 37.9 M |
Cash and Cash Equivalents of other stocks in the Health information services industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
434 M | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
113 M | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
616 M | - | - | $ 27.9 B | USA |
 |
Health Catalyst
HCAT
|
50.8 M | $ 1.1 | -9.5 % | $ 76.9 M | USA |
 |
American Well Corporation
AMWL
|
182 M | $ 5.76 | -0.52 % | $ 92.4 M | USA |
 |
Computer Programs and Systems
CPSI
|
3.85 M | - | 4.4 % | $ 133 M | USA |
 |
HealthStream
HSTM
|
59.5 M | $ 20.97 | -0.76 % | $ 637 M | USA |
 |
Covetrus
CVET
|
183 M | - | - | $ 2.94 B | USA |
 |
iCAD
ICAD
|
17.2 M | - | - | $ 102 M | USA |
 |
NextGen Healthcare
NXGN
|
73.3 M | - | - | $ 1.6 B | USA |
 |
Omnicell
OMCL
|
369 M | $ 34.46 | 0.44 % | $ 1.59 B | USA |
 |
1Life Healthcare
ONEM
|
342 M | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
13.9 M | $ 6.78 | 5.44 % | $ 116 M | USA |
 |
HealthEquity
HQY
|
319 M | $ 82.1 | 0.56 % | $ 7.07 B | USA |
 |
Phreesia
PHR
|
87.5 M | $ 11.28 | -4.41 % | $ 615 M | USA |
 |
Premier
PINC
|
83.7 M | - | - | $ 2.33 B | USA |
 |
Evolent Health
EVH
|
188 M | $ 2.25 | -9.64 % | $ 211 M | USA |
 |
MTBC
MTBC
|
3.12 M | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
448 M | $ 2.04 | -1.92 % | $ 787 M | USA |
 |
Schrödinger
SDGR
|
231 M | $ 11.57 | -2.53 % | $ 850 M | USA |
 |
Signify Health
SGFY
|
466 M | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
130 M | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
735 K | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
188 M | - | -10.39 % | $ 886 M | USA |
 |
Teladoc Health
TDOC
|
781 M | $ 5.42 | -1.09 % | $ 955 M | USA |
 |
Zhongchao
ZCMD
|
15.1 M | $ 1.81 | -4.23 % | $ 9.42 M |  China |
 |
10x Genomics
TXG
|
359 M | $ 19.81 | 3.5 % | $ 2.32 B | USA |
 |
Streamline Health Solutions
STRM
|
2.18 M | - | - | $ 21.4 M | USA |
 |
SCWorx Corp.
WORX
|
107 K | $ 0.13 | -4.16 % | $ 190 K | USA |
 |
Tabula Rasa HealthCare
TRHC
|
70 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
162 M | $ 18.05 | 0.22 % | $ 1.55 B | USA |
 |
So-Young International
SY
|
1.13 B | $ 2.91 | - | $ 231 M | China |
 |
Veeva Systems
VEEV
|
1.42 B | $ 179.11 | -3.3 % | $ 29.3 B | USA |